Document is current

Article History

Accepted: 27 March 2025

First Online: 10 April 2025

Declarations

:

: The authors are currently involved in clinical trials funded by the National Institute of Allergy and Infectious Diseases, Sanofi, Pfizer, Merck, and Moderna that evaluate RSV therapeutics, monoclonal antibodies and vaccines. The authors have also received grant support from the National Institutes of Health and the above pharmaceutical companies for unrelated studies.

: This article does not contain any studies with human or animal subjects performed by any of the authors.